✦ LIBER ✦

Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients

✍ Scribed by Ayca Kaya; Neslihan Aydın; Pınar Topsever; Müge Filiz; Ali Öztürk; Arslan Dağar; Ebru Kılınç; Cem Ekmekcioglu

Book ID: 116313504
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 178 KB
Volume: 58
Category: Article
ISSN: 0753-3322
DOI: 10.1016/j.biopha.2004.09.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of orlistat and sibutramine i

Comparison of orlistat and sibutramine in an obesity management program: Efficacy, compliance, and weight regain after noncompliance

✍ Gursoy, Alptekin; Erdogan, M. F.; Cin, M. O.; Cesur, M.; Baskal, N. 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 133 KB

Short-Term Sibutramine Therapy Is Associ

Short-Term Sibutramine Therapy Is Associated With Weight Loss and Improved Endothelial Function in Obese Patients With Coronary Artery Disease

✍ Michael Shechter; Roy Beigel; Dov Freimark; Shlomi Matetzky; Micha S. Feinberg 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 127 KB

A randomized study of orlistat in combin

A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin

✍ C. Berne; the Orlistat Swedish Type 2 diabetes Study Group 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

A review of the effectiveness of an esta

A review of the effectiveness of an established residential weight management intervention on short-term health outcomes in overweight and obese youth

✍ L. A. Birch 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Efficacy and short-term safety of a new

Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia

✍ William Insull Jr.; Michael Koren; Jean Davignon; Dennis Sprecher; Helmut Schrot 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Effects of Naltrexone Sustained- Release

Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes

✍ Hollander, P.; Gupta, A. K.; Plodkowski, R.; Greenway, F.; Bays, H.; Burns, C.; 📂 Article 📅 2013 🏛 American Diabetes Association 🌐 English ⚖ 682 KB

## OBJECTIVE To assess the efficacy and safety of 32 mg naltrexone sustained-release (SR)/360 mg bupropion SR (NB) in overweight/obese individuals with type 2 diabetes with or without background oral antidiabetes drugs. ## RESEARCH DESIGN AND METHODS This was a 56-week, double-blind, placebo-cont